According to the research report published by Market IntelliX, the global market for Blood Cancer Detection should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Blood Cancer Detection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Blood Cancer Detection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Serve segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Clinical Laboratory has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Blood Cancer Detection include Abbott Laboratories, F.Hoffman-LaRoche, QIAGEN, Thermo Fisher Scientific, lllumina, Bio-Rad Laboratories, MolecularMD, ArcherDX and ARUP Laboratories, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Diagnosis of hematological tumors is the analysis and diagnosis of tumors using blood

This report aims to provide a comprehensive study of the global market for Blood Cancer Detection. Report Highlights:

(1) Global Blood Cancer Detection market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Blood Cancer Detection market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Blood Cancer Detection market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Blood Cancer Detection segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Blood Cancer Detection segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Blood Cancer Detection, capacity, production and trends.

(7) Blood Cancer Detection industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Serve

Detection Kit

Market segment by application, can be divided into

Clinical Laboratory

Hospital

Academic Research Institution

Other

Market segment by players, this report covers

Abbott Laboratories

F.Hoffman-LaRoche

QIAGEN

Thermo Fisher Scientific

lllumina

Bio-Rad Laboratories

MolecularMD

ArcherDX

ARUP Laboratories

Asuragen

Invivoscribe

Adaptive

Biotechnologies

Amoy Diagnostics

ELITechGroup

VelaDiagnostics

Gentronix

BiolVT

SAGA Diagnostics

Olink

Cancer Diagnostics

1 Market Overview

1.1 Blood Cancer Detection Definition

1.2 Global Blood Cancer Detection Market Size and Forecast

1.2.1 By Revenue, Global Blood Cancer Detection Market Size, 2018-2029

1.2.2 By Sales Volume, Global Blood Cancer Detection Market Size, 2018-2029

1.2.3 Global Blood Cancer Detection Price Trend, 2018-2029

1.3 China Blood Cancer Detection Market Size and Forecast

1.3.1 By Revenue, China Blood Cancer Detection Market Size, 2018-2029

1.3.2 By Sales Volume, China Blood Cancer Detection Market Size, 2018-2029

1.3.3 China Blood Cancer Detection Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Blood Cancer Detection Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Blood Cancer Detection Share in Global Market, 2018-2029

1.4.3 Blood Cancer Detection Market Size: China VS Global, 2018-2029

1.5 Blood Cancer Detection Market Dynamics

1.5.1 Blood Cancer Detection Market Drivers

1.5.2 Blood Cancer Detection Market Restraints

1.5.3 Blood Cancer Detection Industry Trends

1.5.4 Blood Cancer Detection Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Blood Cancer Detection Revenue by Company, 2018-2023

2.2 Global Blood Cancer Detection Sales Volume by Company, 2018-2023

2.3 Global Blood Cancer Detection Price by Company, 2018-2023

2.4 Global Blood Cancer Detection Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Blood Cancer Detection Concentration Ratio

2.6 Global Blood Cancer Detection Mergers & Acquisitions, Expansion Plans

2.7 Global Blood Cancer Detection Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Blood Cancer Detection Revenue by Company, 2018-2023

3.2 China Blood Cancer Detection Sales Volume by Company, 2018-2023

3.3 China Blood Cancer Detection Blood Cancer Detection Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Blood Cancer Detection Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Blood Cancer Detection Domestic VS Export

3.6 China Market, Blood Cancer Detection Import & Export

3.6.1 China Market, Blood Cancer Detection Import & Export, 2018-2029

3.6.2 China Blood Cancer Detection Import & Export Trends

3.6.3 Main Sources of China Blood Cancer Detection Import

3.6.4 Export Destination of China Blood Cancer Detection

4 Blood Cancer Detection Production by Region

4.1 Global Blood Cancer Detection Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Blood Cancer Detection Manufacturers

4.3 Global Major Manufacturers, Blood Cancer Detection Capacity Expansion and Future Plans

4.4 Global Blood Cancer Detection Capacity by Region

4.5 Global Blood Cancer Detection Production by Region

4.5.1 Global Blood Cancer Detection Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Blood Cancer Detection Production by Region, 2018-2023

4.5.3 Global Blood Cancer Detection Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Blood Cancer Detection Industry Chain

5.2 Blood Cancer Detection Upstream Analysis

5.2.1 Blood Cancer Detection Core Raw Materials

5.2.2 Main Manufacturers of Blood Cancer Detection Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Blood Cancer Detection Production Mode

5.6 Blood Cancer Detection Procurement Model

5.7 Blood Cancer Detection Industry Sales Model and Sales Channels

5.7.1 Blood Cancer Detection Sales Model

5.7.2 Blood Cancer Detection Typical Distributors

6 Sights by Type

6.1 Blood Cancer Detection Classification

6.1.1 Serve

6.1.2 Detection Kit

6.2 By Type, Global Blood Cancer Detection Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Blood Cancer Detection Revenue, 2018-2029

6.4 By Type, Global Blood Cancer Detection Sales Volume, 2018-2029

6.5 By Type, Global Blood Cancer Detection Price, 2018-2029

7 Sights by Application

7.1 Blood Cancer Detection Segment by Application

7.1.1 Clinical Laboratory

7.1.2 Hospital

7.1.3 Academic Research Institution

7.1.4 Other

7.2 By Application, Global Blood Cancer Detection Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Blood Cancer Detection Revenue, 2018-2029

7.4 By Application, Global Blood Cancer Detection Sales Volume, 2018-2029

7.5 By Application, Global Blood Cancer Detection Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Blood Cancer Detection Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Blood Cancer Detection Revenue, 2018-2029

8.3 By Region, Global Blood Cancer Detection Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Blood Cancer Detection Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Blood Cancer Detection Market Size Market Share

8.5 Europe

8.5.1 Europe Blood Cancer Detection Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Blood Cancer Detection Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Blood Cancer Detection Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Blood Cancer Detection Market Size Market Share

8.7 South America

8.7.1 South America Blood Cancer Detection Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Blood Cancer Detection Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Blood Cancer Detection Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Blood Cancer Detection Revenue, 2018-2029

9.3 By Country, Global Blood Cancer Detection Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Blood Cancer Detection Market Size, 2018-2029

9.4.2 By Company, U.S. Blood Cancer Detection Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Blood Cancer Detection Market Size, 2018-2029

9.5.2 By Company, Europe Blood Cancer Detection Sales Volume Market Share, 2022

9.5.3 By Type, Europe Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Blood Cancer Detection Market Size, 2018-2029

9.6.2 By Company, China Blood Cancer Detection Sales Volume Market Share, 2022

9.6.3 By Type, China Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Blood Cancer Detection Market Size, 2018-2029

9.7.2 By Company, Japan Blood Cancer Detection Sales Volume Market Share, 2022

9.7.3 By Type, Japan Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Blood Cancer Detection Market Size, 2018-2029

9.8.2 By Company, South Korea Blood Cancer Detection Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Blood Cancer Detection Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Blood Cancer Detection Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Blood Cancer Detection Market Size, 2018-2029

9.10.2 By Company, India Blood Cancer Detection Sales Volume Market Share, 2022

9.10.3 By Type, India Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Blood Cancer Detection Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Blood Cancer Detection Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Blood Cancer Detection Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Blood Cancer Detection Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Abbott Laboratories

10.1.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

10.1.2 Abbott Laboratories Blood Cancer Detection Models, Specifications and Application

10.1.3 Abbott Laboratories Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Abbott Laboratories Company Profile and Main Business

10.1.5 Abbott Laboratories Recent Developments

10.2 F.Hoffman-LaRoche

10.2.1 F.Hoffman-LaRoche Company Information, Head Office, Market Area and Industry Position

10.2.2 F.Hoffman-LaRoche Blood Cancer Detection Models, Specifications and Application

10.2.3 F.Hoffman-LaRoche Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 F.Hoffman-LaRoche Company Profile and Main Business

10.2.5 F.Hoffman-LaRoche Recent Developments

10.3 QIAGEN

10.3.1 QIAGEN Company Information, Head Office, Market Area and Industry Position

10.3.2 QIAGEN Blood Cancer Detection Models, Specifications and Application

10.3.3 QIAGEN Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 QIAGEN Company Profile and Main Business

10.3.5 QIAGEN Recent Developments

10.4 Thermo Fisher Scientific

10.4.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

10.4.2 Thermo Fisher Scientific Blood Cancer Detection Models, Specifications and Application

10.4.3 Thermo Fisher Scientific Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Thermo Fisher Scientific Company Profile and Main Business

10.4.5 Thermo Fisher Scientific Recent Developments

10.5 lllumina

10.5.1 lllumina Company Information, Head Office, Market Area and Industry Position

10.5.2 lllumina Blood Cancer Detection Models, Specifications and Application

10.5.3 lllumina Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 lllumina Company Profile and Main Business

10.5.5 lllumina Recent Developments

10.6 Bio-Rad Laboratories

10.6.1 Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position

10.6.2 Bio-Rad Laboratories Blood Cancer Detection Models, Specifications and Application

10.6.3 Bio-Rad Laboratories Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Bio-Rad Laboratories Company Profile and Main Business

10.6.5 Bio-Rad Laboratories Recent Developments

10.7 MolecularMD

10.7.1 MolecularMD Company Information, Head Office, Market Area and Industry Position

10.7.2 MolecularMD Blood Cancer Detection Models, Specifications and Application

10.7.3 MolecularMD Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 MolecularMD Company Profile and Main Business

10.7.5 MolecularMD Recent Developments

10.8 ArcherDX

10.8.1 ArcherDX Company Information, Head Office, Market Area and Industry Position

10.8.2 ArcherDX Blood Cancer Detection Models, Specifications and Application

10.8.3 ArcherDX Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 ArcherDX Company Profile and Main Business

10.8.5 ArcherDX Recent Developments

10.9 ARUP Laboratories

10.9.1 ARUP Laboratories Company Information, Head Office, Market Area and Industry Position

10.9.2 ARUP Laboratories Blood Cancer Detection Models, Specifications and Application

10.9.3 ARUP Laboratories Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 ARUP Laboratories Company Profile and Main Business

10.9.5 ARUP Laboratories Recent Developments

10.10 Asuragen

10.10.1 Asuragen Company Information, Head Office, Market Area and Industry Position

10.10.2 Asuragen Blood Cancer Detection Models, Specifications and Application

10.10.3 Asuragen Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Asuragen Company Profile and Main Business

10.10.5 Asuragen Recent Developments

10.11 Invivoscribe

10.11.1 Invivoscribe Company Information, Head Office, Market Area and Industry Position

10.11.2 Invivoscribe Blood Cancer Detection Models, Specifications and Application

10.11.3 Invivoscribe Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Invivoscribe Company Profile and Main Business

10.11.5 Invivoscribe Recent Developments

10.12 Adaptive

Biotechnologies

10.12.1 Adaptive

Biotechnologies Company Information, Head Office, Market Area and Industry Position

10.12.2 Adaptive

Biotechnologies Blood Cancer Detection Models, Specifications and Application

10.12.3 Adaptive

Biotechnologies Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 Adaptive

Biotechnologies Company Profile and Main Business

10.12.5 Adaptive

Biotechnologies Recent Developments

10.13 Amoy Diagnostics

10.13.1 Amoy Diagnostics Company Information, Head Office, Market Area and Industry Position

10.13.2 Amoy Diagnostics Blood Cancer Detection Models, Specifications and Application

10.13.3 Amoy Diagnostics Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Amoy Diagnostics Company Profile and Main Business

10.13.5 Amoy Diagnostics Recent Developments

10.14 ELITechGroup

10.14.1 ELITechGroup Company Information, Head Office, Market Area and Industry Position

10.14.2 ELITechGroup Blood Cancer Detection Models, Specifications and Application

10.14.3 ELITechGroup Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.14.4 ELITechGroup Company Profile and Main Business

10.14.5 ELITechGroup Recent Developments

10.15 VelaDiagnostics

10.15.1 VelaDiagnostics Company Information, Head Office, Market Area and Industry Position

10.15.2 VelaDiagnostics Blood Cancer Detection Models, Specifications and Application

10.15.3 VelaDiagnostics Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.15.4 VelaDiagnostics Company Profile and Main Business

10.15.5 VelaDiagnostics Recent Developments

10.16 Gentronix

10.16.1 Gentronix Company Information, Head Office, Market Area and Industry Position

10.16.2 Gentronix Blood Cancer Detection Models, Specifications and Application

10.16.3 Gentronix Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.16.4 Gentronix Company Profile and Main Business

10.16.5 Gentronix Recent Developments

10.17 BiolVT

10.17.1 BiolVT Company Information, Head Office, Market Area and Industry Position

10.17.2 BiolVT Blood Cancer Detection Models, Specifications and Application

10.17.3 BiolVT Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.17.4 BiolVT Company Profile and Main Business

10.17.5 BiolVT Recent Developments

10.18 SAGA Diagnostics

10.18.1 SAGA Diagnostics Company Information, Head Office, Market Area and Industry Position

10.18.2 SAGA Diagnostics Blood Cancer Detection Models, Specifications and Application

10.18.3 SAGA Diagnostics Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.18.4 SAGA Diagnostics Company Profile and Main Business

10.18.5 SAGA Diagnostics Recent Developments

10.19 Olink

10.19.1 Olink Company Information, Head Office, Market Area and Industry Position

10.19.2 Olink Blood Cancer Detection Models, Specifications and Application

10.19.3 Olink Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.19.4 Olink Company Profile and Main Business

10.19.5 Olink Recent Developments

10.20 Cancer Diagnostics

10.20.1 Cancer Diagnostics Company Information, Head Office, Market Area and Industry Position

10.20.2 Cancer Diagnostics Blood Cancer Detection Models, Specifications and Application

10.20.3 Cancer Diagnostics Blood Cancer Detection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.20.4 Cancer Diagnostics Company Profile and Main Business

10.20.5 Cancer Diagnostics Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Blood Cancer Detection Market Size & CAGR: China VS Global, 2018-2029, US$ Million_x000D_

Table 2. Blood Cancer Detection Market Restraints_x000D_

Table 3. Blood Cancer Detection Market Trends_x000D_

Table 4. Blood Cancer Detection Industry Policy_x000D_

Table 5. Global Blood Cancer Detection Revenue by Company, 2018-2023, US$ million_x000D_

Table 6. Global Blood Cancer Detection Revenue Market Share by Company, 2018-2023_x000D_

Table 7. Global Blood Cancer Detection Sales Volume by Company, 2018-2023, (K Units)_x000D_

Table 8. Global Blood Cancer Detection Sales Volume Market Share by Company, 2018-2023_x000D_

Table 9. Global Blood Cancer Detection Price by Company, 2018-2023, (US$/Unit)_x000D_

Table 10. Global Blood Cancer Detection Manufacturers Market Concentration Ratio (CR3 and HHI)_x000D_

Table 11. Global Blood Cancer Detection Mergers & Acquisitions, Expansion Plans_x000D_

Table 12. Global Blood Cancer Detection Manufacturers Product Type_x000D_

Table 13. China Blood Cancer Detection Revenue by Company, 2018-2023, US$ million_x000D_

Table 14. China Blood Cancer Detection Revenue Market Share by Company, 2018-2023_x000D_

Table 15. China Blood Cancer Detection Sales Volume by Company, 2018-2023, (K Units)_x000D_

Table 16. China Blood Cancer Detection Sales Volume Market Share by Company, 2018-2023_x000D_

Table 17. China Market, Blood Cancer Detection Production, Sales, Import and Export, 2018-2029, (K Units)_x000D_

Table 18. China Blood Cancer Detection Import & Export Trends_x000D_

Table 19. Main Sources of China Blood Cancer Detection Import_x000D_

Table 20. Export Destination of China Blood Cancer Detection_x000D_

Table 21. Global Headquarters and Manufacturing Base of Blood Cancer Detection Manufacturers_x000D_

Table 22. Global Major Manufacturers, Blood Cancer Detection Capacity Expansion and Future Plans_x000D_

Table 23. Global Blood Cancer Detection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)_x000D_

Table 24. Global Blood Cancer Detection Production by Region, 2018-2023, (K Units)_x000D_

Table 25. Global Blood Cancer Detection Production Forecast by Region, 2023-2029, (K Units)_x000D_

Table 26. Global Key Players of Blood Cancer Detection Upstream (Raw Materials)_x000D_

Table 27. Global Blood Cancer Detection Typical Customers_x000D_

Table 28. Blood Cancer Detection Typical Distributors_x000D_

Table 29. By Type, Global Blood Cancer Detection Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 30. By Application, Global Blood Cancer Detection Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 31. By Region, Global Blood Cancer Detection Market Size, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 32. By Region, Global Blood Cancer Detection Revenue, 2018-2029, US$ Million_x000D_

Table 33. By Region, Global Blood Cancer Detection Sales Volume, 2018-2029, (K Units)_x000D_

Table 34. By Country, Global Blood Cancer Detection Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million_x000D_

Table 35. By Country, Global Blood Cancer Detection Revenue, 2018-2029, US$ Million_x000D_

Table 36. By Country, Global Blood Cancer Detection Revenue Market Share, 2018-2029_x000D_

Table 37. By Country, Global Blood Cancer Detection Sales Volume, 2018-2029, (K Units)_x000D_

Table 38. By Country, Global Blood Cancer Detection Sales Volume Market Share, 2018-2029_x000D_

Table 39. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position_x000D_

Table 40. Abbott Laboratories Blood Cancer Detection Models, Specifications and Application_x000D_

Table 41. Abbott Laboratories Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 42. Abbott Laboratories Company Profile and Main Business_x000D_

Table 43. Abbott Laboratories Recent Developments_x000D_

Table 44. F.Hoffman-LaRoche Company Information, Head Office, Market Area and Industry Position_x000D_

Table 45. F.Hoffman-LaRoche Blood Cancer Detection Models, Specifications and Application_x000D_

Table 46. F.Hoffman-LaRoche Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 47. F.Hoffman-LaRoche Company Profile and Main Business_x000D_

Table 48. F.Hoffman-LaRoche Recent Developments_x000D_

Table 49. QIAGEN Company Information, Head Office, Market Area and Industry Position_x000D_

Table 50. QIAGEN Blood Cancer Detection Models, Specifications and Application_x000D_

Table 51. QIAGEN Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 52. QIAGEN Company Profile and Main Business_x000D_

Table 53. QIAGEN Recent Developments_x000D_

Table 54. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position_x000D_

Table 55. Thermo Fisher Scientific Blood Cancer Detection Models, Specifications and Application_x000D_

Table 56. Thermo Fisher Scientific Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 57. Thermo Fisher Scientific Company Profile and Main Business_x000D_

Table 58. Thermo Fisher Scientific Recent Developments_x000D_

Table 59. lllumina Company Information, Head Office, Market Area and Industry Position_x000D_

Table 60. lllumina Blood Cancer Detection Models, Specifications and Application_x000D_

Table 61. lllumina Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 62. lllumina Company Profile and Main Business_x000D_

Table 63. lllumina Recent Developments_x000D_

Table 64. Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position_x000D_

Table 65. Bio-Rad Laboratories Blood Cancer Detection Models, Specifications and Application_x000D_

Table 66. Bio-Rad Laboratories Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 67. Bio-Rad Laboratories Company Profile and Main Business_x000D_

Table 68. Bio-Rad Laboratories Recent Developments_x000D_

Table 69. MolecularMD Company Information, Head Office, Market Area and Industry Position_x000D_

Table 70. MolecularMD Blood Cancer Detection Models, Specifications and Application_x000D_

Table 71. MolecularMD Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 72. MolecularMD Company Profile and Main Business_x000D_

Table 73. MolecularMD Recent Developments_x000D_

Table 74. ArcherDX Company Information, Head Office, Market Area and Industry Position_x000D_

Table 75. ArcherDX Blood Cancer Detection Models, Specifications and Application_x000D_

Table 76. ArcherDX Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 77. ArcherDX Company Profile and Main Business_x000D_

Table 78. ArcherDX Recent Developments_x000D_

Table 79. ARUP Laboratories Company Information, Head Office, Market Area and Industry Position_x000D_

Table 80. ARUP Laboratories Blood Cancer Detection Models, Specifications and Application_x000D_

Table 81. ARUP Laboratories Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 82. ARUP Laboratories Company Profile and Main Business_x000D_

Table 83. ARUP Laboratories Recent Developments_x000D_

Table 84. Asuragen Company Information, Head Office, Market Area and Industry Position_x000D_

Table 85. Asuragen Blood Cancer Detection Models, Specifications and Application_x000D_

Table 86. Asuragen Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 87. Asuragen Company Profile and Main Business_x000D_

Table 88. Asuragen Recent Developments_x000D_

Table 89. Invivoscribe Company Information, Head Office, Market Area and Industry Position_x000D_

Table 90. Invivoscribe Blood Cancer Detection Models, Specifications and Application_x000D_

Table 91. Invivoscribe Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 92. Invivoscribe Company Profile and Main Business_x000D_

Table 93. Invivoscribe Recent Developments_x000D_

Table 94. Adaptive

Biotechnologies Company Information, Head Office, Market Area and Industry Position_x000D_

Table 95. Adaptive

Biotechnologies Blood Cancer Detection Models, Specifications and Application_x000D_

Table 96. Adaptive

Biotechnologies Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 97. Adaptive

Biotechnologies Company Profile and Main Business_x000D_

Table 98. Adaptive

Biotechnologies Recent Developments_x000D_

Table 99. Amoy Diagnostics Company Information, Head Office, Market Area and Industry Position_x000D_

Table 100. Amoy Diagnostics Blood Cancer Detection Models, Specifications and Application_x000D_

Table 101. Amoy Diagnostics Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 102. Amoy Diagnostics Company Profile and Main Business_x000D_

Table 103. Amoy Diagnostics Recent Developments_x000D_

Table 104. ELITechGroup Company Information, Head Office, Market Area and Industry Position_x000D_

Table 105. ELITechGroup Blood Cancer Detection Models, Specifications and Application_x000D_

Table 106. ELITechGroup Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 107. ELITechGroup Company Profile and Main Business_x000D_

Table 108. ELITechGroup Recent Developments_x000D_

Table 109. VelaDiagnostics Company Information, Head Office, Market Area and Industry Position_x000D_

Table 110. VelaDiagnostics Blood Cancer Detection Models, Specifications and Application_x000D_

Table 111. VelaDiagnostics Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 112. VelaDiagnostics Company Profile and Main Business_x000D_

Table 113. VelaDiagnostics Recent Developments_x000D_

Table 114. Gentronix Company Information, Head Office, Market Area and Industry Position_x000D_

Table 115. Gentronix Blood Cancer Detection Models, Specifications and Application_x000D_

Table 116. Gentronix Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 117. Gentronix Company Profile and Main Business_x000D_

Table 118. Gentronix Recent Developments_x000D_

Table 119. BiolVT Company Information, Head Office, Market Area and Industry Position_x000D_

Table 120. BiolVT Blood Cancer Detection Models, Specifications and Application_x000D_

Table 121. BiolVT Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 122. BiolVT Company Profile and Main Business_x000D_

Table 123. BiolVT Recent Developments_x000D_

Table 124. SAGA Diagnostics Company Information, Head Office, Market Area and Industry Position_x000D_

Table 125. SAGA Diagnostics Blood Cancer Detection Models, Specifications and Application_x000D_

Table 126. SAGA Diagnostics Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 127. SAGA Diagnostics Company Profile and Main Business_x000D_

Table 128. SAGA Diagnostics Recent Developments_x000D_

Table 129. Olink Company Information, Head Office, Market Area and Industry Position_x000D_

Table 130. Olink Blood Cancer Detection Models, Specifications and Application_x000D_

Table 131. Olink Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 132. Olink Company Profile and Main Business_x000D_

Table 133. Olink Recent Developments_x000D_

Table 134. Cancer Diagnostics Company Information, Head Office, Market Area and Industry Position_x000D_

Table 135. Cancer Diagnostics Blood Cancer Detection Models, Specifications and Application_x000D_

Table 136. Cancer Diagnostics Blood Cancer Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 137. Cancer Diagnostics Company Profile and Main Business_x000D_

Table 138. Cancer Diagnostics Recent Developments_x000D_

List of Figure_x000D_

Figure 1. Blood Cancer Detection Picture_x000D_

Figure 2. By Revenue, Global Blood Cancer Detection Market Size and Forecast, 2018-2029, US$ Million_x000D_

Figure 3. By Sales Volume, Global Blood Cancer Detection Market Size and Forecast, 2018-2029, (K Units)_x000D_

Figure 4. Global Blood Cancer Detection Price Trend, 2018-2029, (US$/Unit)_x000D_

Figure 5. By Revenue, China Blood Cancer Detection Market Size and Forecast, 2018-2029, US$ million_x000D_

Figure 6. By Sales Volume, China Blood Cancer Detection Market Size and Forecast, 2018-2029, (K Units)_x000D_

Figure 7. China Blood Cancer Detection Price Trend, 2018-2029 (US$/Unit)_x000D_

Figure 8. By Revenue, China Blood Cancer Detection Share of Global Market, 2018-2029_x000D_

Figure 9. By Sales Volume, China Blood Cancer Detection Share of Global Market, 2018-2029_x000D_

Figure 10. Global Blood Cancer Detection Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 11. Global Blood Cancer Detection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022_x000D_

Figure 12. China Blood Cancer Detection Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 13. China Blood Cancer Detection Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 14. China Blood Cancer Detection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023_x000D_

Figure 15. Chinese Local Players, Proportion of Blood Cancer Detection Domestic VS Export, 2022_x000D_

Figure 16. Global Blood Cancer Detection Capacity, Production and Capacity Utilization, 2018-2029_x000D_

Figure 17. Global Blood Cancer Detection Capacity Market Share by Region, 2022 VS 2029_x000D_

Figure 18. Global Blood Cancer Detection Production Market Share & Forecast by Region, 2018-2029_x000D_

Figure 19. Blood Cancer Detection Industry Chain_x000D_

Figure 20. Blood Cancer Detection Procurement Model_x000D_

Figure 21. Blood Cancer Detection Sales Model_x000D_

Figure 22. Blood Cancer Detection Sales Channels, Direct Sales and Distribution_x000D_

Figure 23. Serve_x000D_

Figure 24. Detection Kit_x000D_

Figure 25. By Type, Global Blood Cancer Detection Revenue, 2018-2029, US$ Million_x000D_

Figure 26. By Type, Global Blood Cancer Detection Revenue Market Share, 2018-2029_x000D_

Figure 27. By Type, Global Blood Cancer Detection Sales Volume, 2018-2029, (K Units)_x000D_

Figure 28. By Type, Global Blood Cancer Detection Sales Volume Market Share, 2018-2029_x000D_

Figure 29. By Type, Global Blood Cancer Detection Price, 2018-2029, (US$/Unit)_x000D_

Figure 30. Clinical Laboratory_x000D_

Figure 31. Hospital_x000D_

Figure 32. Academic Research Institution_x000D_

Figure 33. Other_x000D_

Figure 34. By Application, Global Blood Cancer Detection Revenue, 2018-2029, US$ Million_x000D_

Figure 35. By Application, Global Blood Cancer Detection Revenue Market Share, 2018-2029_x000D_

Figure 36. By Application, Global Blood Cancer Detection Sales Volume, 2018-2029, (K Units)_x000D_

Figure 37. By Application, Global Blood Cancer Detection Sales Volume Market Share, 2018-2029_x000D_

Figure 38. By Application, Global Blood Cancer Detection Price, 2018-2029, (US$/Unit)_x000D_

Figure 39. By Region, Global Blood Cancer Detection Revenue Market Share, 2018-2029_x000D_

Figure 40. By Region, Global Blood Cancer Detection Sales Volume Market Share, 2018-2029_x000D_

Figure 41. North America Blood Cancer Detection Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 42. By Country, North America Blood Cancer Detection Revenue Market Share, 2022_x000D_

Figure 43. Europe Blood Cancer Detection Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 44. By Country, Europe Blood Cancer Detection Revenue Market Share, 2022_x000D_

Figure 45. Asia Pacific Blood Cancer Detection Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 46. By Country/Region, Asia Pacific Blood Cancer Detection Revenue Market Share, 2022_x000D_

Figure 47. South America Blood Cancer Detection Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 48. By Country, South America Blood Cancer Detection Revenue Market Share, 2022_x000D_

Figure 49. Middle East & Africa Blood Cancer Detection Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 50. U.S. Blood Cancer Detection Sales Volume, 2018-2029, (K Units)_x000D_

Figure 51. By Company, U.S. Blood Cancer Detection Market Share, 2022_x000D_

Figure 52. By Type, U.S. Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 53. By Application, U.S. Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 54. Europe Blood Cancer Detection Sales Volume, 2018-2029, (K Units)_x000D_

Figure 55. By Company, Europe Blood Cancer Detection Market Share, 2022_x000D_

Figure 56. By Type, Europe Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 57. By Application, Europe Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 58. China Blood Cancer Detection Sales Volume, 2018-2029, (K Units)_x000D_

Figure 59. By Company, China Blood Cancer Detection Market Share, 2022_x000D_

Figure 60. By Type, China Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 61. By Application, China Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 62. Japan Blood Cancer Detection Sales Volume, 2018-2029, (K Units)_x000D_

Figure 63. By Company, Japan Blood Cancer Detection Market Share, 2022_x000D_

Figure 64. By Type, Japan Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 65. By Application, Japan Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 66. South Korea Blood Cancer Detection Sales Volume, 2018-2029, (K Units)_x000D_

Figure 67. By Company, South Korea Blood Cancer Detection Market Share, 2022_x000D_

Figure 68. By Type, South Korea Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 69. By Application, South Korea Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 70. Southeast Asia Blood Cancer Detection Sales Volume, 2018-2029, (K Units)_x000D_

Figure 71. By Company, Southeast Asia Blood Cancer Detection Market Share, 2022_x000D_

Figure 72. By Type, Southeast Asia Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 73. By Application, Southeast Asia Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 74. India Blood Cancer Detection Sales Volume, 2018-2029, (K Units)_x000D_

Figure 75. By Company, India Blood Cancer Detection Market Share, 2022_x000D_

Figure 76. By Type, India Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 77. By Application, India Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 78. Middle East & Asia Blood Cancer Detection Sales Volume, 2018-2029, (K Units)_x000D_

Figure 79. By Company, Middle East & Asia Blood Cancer Detection Market Share, 2022_x000D_

Figure 80. By Type, Middle East & Asia Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 81. By Application, Middle East & Asia Blood Cancer Detection Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 82. Research Methodology_x000D_

Figure 83. Breakdown of Primary Interviews_x000D_

Figure 84. Bottom-up Approaches_x000D_

Figure 85. Top-down Approaches_x000D_

_x000D_

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)